Tag: Health
Jim O’Neill Named HHS Deputy Secretary by Trump: Biotech Investor
President-elect Trump has selected biotech investor Jim O'Neill as the nominee for deputy secretary of the Health and Human Services department. If confirmed, O'Neill...
Jay Bhattacharya: Trump’s Choice to Lead NIH
President-elect Trump has made his selection for the role of leading the National Institutes of Health known, with Stanford University professor Jay Bhattacharya being...
Roche Lung Cancer Study: Immunotherapy Failures and Drug Target Questions
Roche, a pharmaceutical company, recently announced that an experimental cancer treatment they were working on, called tiragolumab, did not improve survival rates in a...
Title: Analysis of Alector Therapeutics’ Alzheimer’s Treatment Failure in Phase 2 Study
Alector Therapeutics announced that their Phase 2 trial for a potential Alzheimer's antibody, known as AL002, was unsuccessful. This setback is disappointing as the...
The End of Cassava Sciences and its Alzheimer’s Drug: Lingering Damage
The story of Cassava Sciences came to a disappointing end on Monday when their experimental drug for Alzheimer's disease, simufilam, was found to be...
Optimistic Vaccine Activist: Embracing Hope for the Future
The United States is facing an uncertain future when it comes to vaccine policy. With potential appointees like Robert F. Kennedy Jr., Mehmet Oz,...
Pfizer’s New R&D Head, VC Deep-Dive, and FDA Commissioner: What You Need to Know
Pfizer has welcomed a new R&D head, Chris Boshoff, who is expected to make significant strides in research and development to satisfy investors. Additionally,...
FAQs: Understanding IGAs in Animals
Intentional Genomic Alterations (IGAs) in animals refer to changes made to an animal's DNA using modern molecular technologies. These alterations can include targeted DNA...
Novartis Acquires Kate Therapeutics to Advance Muscular Dystrophy Treatment
Novartis made a significant move in the field of gene therapy by acquiring Kate Therapeutics for up to $1.1 billion. This acquisition includes not...
Kura Oncology Licenses Leukemia Drug to Japanese Drugmaker
Kura Oncology and the Japanese drugmaker Kyowa Kirin have joined forces in a global partnership to work on Kura’s new treatment for acute leukemia....
Medicaid Official Criticizes Republican Reform as Poor Policy
Medicaid, a program that provides health coverage to millions of low-income Americans, is facing potential cuts as Republicans look to fund tax cuts and...
Apellis Triumphs while Astellas Faces Defeat
Good morning! Today, there is a lot of news from the American Heart Association's annual meeting, and former National Cancer Institute chief Ned Sharpless...